Among these, TRIM28 was prioritized due to its established role in reducing ubiquitin-mediated degradation of oncogenic proteins such as PD-L1, TRIM24 and YTHDC1 [31–33], as well as its involvement in BLCA progression via hTERT transcriptional activation [34]. The gene discussed is CD274; the disease is bladder transitional cell carcinoma.